Surface antigens of Plasmodium falciparum gametocytes-A new class of transmission-blocking vaccine targets?

Molecular and Biochemical Parasitology

Volumn 166, Issue 2, 2009, Pages 93-98

  Sutherland, Colin J ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

Gametocytes; Malaria; Transmission blocking vaccines

Indexed keywords

MEMBRANE ANTIGEN; PARASITE ANTIBODY; VACCINE;

ERYTHROCYTE; FLOW CYTOMETRY; GAMETE; GAMETOCYTE; GENE EXPRESSION; HOST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION CONTROL; MALARIA; MALARIA CONTROL; MOLECULAR RECOGNITION; MULTIGENE FAMILY; NONHUMAN; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; GERM CELLS; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 67349215716     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2009.03.007     Document Type: Review

References (43)

1. Roberts D.J., Craig A.G., Berendt A.R., et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357 (1992) 689-692
2. Preiser P.R., Khan S., Costa F.T., et al. Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle. Science 295 (2002) 342-345
3. Hommel M., and David P.H. Plasmodium knowlesi variant antigens are found on schizont-infected erythrocytes but not on merozoites. Infect Immun 33 (1981) 275-284
4. Nacher M. Does the shape of Plasmodium falciparum gametocytes have a function?. Med Hypotheses 62 (2004) 618-619
5. Eichner M., Diebner H.H., Molineaux L., Collins W.E., Jeffery G.M., and Dietz K. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg 95 (2001) 497-501
6. Naotunne T.S., Karunaweera N.D., Mendis K.N., and Carter R. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 78 (1993) 555-562
7. McKenzie F.E., Jeffery G.M., and Collins W.E. Gametocytemia and fever in human malaria infections. J Parasitol 93 (2007) 627-633
8. Day K.P., Hayward R.E., Smith D., and Culvenor J.G. CD36-dependent adhesion and knob expression of the transmission stages of Plasmodium falciparum is stage-specific. Mol Biochem Parasitol 93 (1998) 167-177
9. Rogers N.J., Hall B.S., Obiero J., Targett G.A.T., and Sutherland C.J. A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone-marrow cells. Infect Immun 68 (2000) 3455-3462
10. Pichon G., Awono-Ambene H.P., and Robert V. High heterogeneity in the number of Plasmodium falciparum gametocytes in the bloodmeal of mosquitoes fed on the same host. Parasitology 121 (2000) 115-120
11. Hawking F., Wilson M.E., and Gammage K. Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg 65 (1971) 549-559
12. Magesa S.M., Mdira Y.K., Akida J.A., Bygbjerg I.C., and Jakobsen P.H. Observations on the periodicity of Plasmodium falciparum gametocytes in natural human infections. Acta Trop 76 (2000) 239-246
13. van der Kolk M., de Vlas S.J., Saul A., van de Vegte-Bolmer M., Eling W.M., and Sauerwein R.W. Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology 130 (2005) 13-22
14. Miura K., Keister D.B., Muratova O.V., Sattabongkot J., Long C.A., and Saul A. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malar J 6 (2007) 107
15. Outchkourov N.S., Roeffen W., Kaan A., et al. Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Proc Natl Acad Sci USA 105 (2008) 4301-4305
16. Saul A. Mosquito stage, transmission blocking vaccines for malaria. Curr Opin Infect Dis 20 (2007) 476-481
17. Wu Y., Ellis R.D., Shaffer D., et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS ONE 3 (2008) e2636
18. van Schaijk B.C., van Dijk M.R., van de Vegte-Bolmer M., et al. Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum. Mol Biochem Parasitol 149 (2006) 216-222
19. Tsuboi T., Kaslow D.C., Gozar M.M., Tachibana M., Cao Y.M., and Torii M. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol Med 4 (1998) 772-782
20. Templeton T.J., and Kaslow D.C. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol Biochem Parasitol 101 (1999) 223-227
21. Pradel G., Hayton K., Aravind L., et al. A multidomain adhesion protein family expressed in Plasmodium falciparum is essential for transmission to the mosquito. J Exp Med 199 (2004) 1533-1544
22. Healer J., McGuinness D., Hopcroft P., Haley S., Carter R., and Riley E. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect Immun 65 (1997) 3017-3023
23. Stowers A., and Carter R. Current developments in malaria transmission-blocking vaccines. Expert Opin Biol Ther 1 (2001) 619-628
24. Schneider P., Schoone G., Schallig H., et al. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol Biochem Parasitol 137 (2004) 35-41
25. Smalley M.E., Abdalla S., and Brown J. The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children. Trans Roy Soc Trop Med Hyg 75 (1980) 103-105
26. Hayward R.E., Tiwari B., Piper K.P., Baruch D.I., and Day K.P. Virulence and transmission success of the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci USA 96 (1999) 4563-4568
27. Lavazec C., Sanyal S., and Templeton T.J. Expression switching in the stevor and Pfmc-2TM superfamilies in Plasmodium falciparum. Mol Microbiol 64 (2007) 1621-1634
28. Sutherland C.J. Stevor transcripts from Plasmodium falciparum gametocytes encode truncated polypeptides. Mol Biochem Parasitol 113 (2001) 331-335
29. Sharp S., Lavstsen T., Fivelman Q.L., et al. Programmed transcription of the var gene family, but not of stevor, in Plasmodium falciparum gametocytes. Eukaryot Cell 5 (2006) 1206-1214
30. McRobert L., Preiser P., Kaviratne M., et al. Distinct trafficking and localization of STEVOR proteins in three life-cycle compartments of Plasmodium falciparum. Infect Immun 72 (2004) 6597-6602
31. Jensen A.T., Magistrado P., Sharp S., et al. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med 199 (2004) 1179-1190
32. Blythe J.E., Yam X.Y., Kuss C., et al. Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites. Infect Immun 76 (2008) 3329-3336
33. Eksi S., Haile Y., Furuya T., Ma L., Su X., and Williamson K.C. Identification of a subtelomeric gene family expressed during the asexual-sexual stage transition in Plasmodium falciparum. Mol Biochem Parasitol 143 (2005) 90-99
34. Young J.A., Fivelman Q.L., Blair P.L., et al. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. Mol Biochem Parasitol 143 (2005) 67-79
35. Florens L., Washburn M.P., Raine J.D., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419 (2002) 520-526
36. Lasonder E., Ishihama Y., Andersen J.S., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419 (2002) 537-542
37. Saeed M., Roeffen W., Alexander N., Drakeley C.J., Targett G.A.T., and Sutherland C.J. Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS ONE 3 (2008) e2280 10.1371/journal. pone.0002280
38. Sutherland C.J., Drakeley C.J., Obisike U., et al. The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent, treatment failure. Am J Trop Med Hyg 69 1 (2003) 19-25
39. Sutherland C.J., Ord R., Dunyo S., et al. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of Co-artemether. PLoS Med 2 4 (2005) e92
40. Drakeley C.J., Jawara M., Targett G.A.T., et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes Trop. Med Int Health 9 (2004) 53-61
41. Greenwood B.M. Control to elimination: implications for malaria research. Trends Parasitol 24 (2008) 449-454
42. Sharp S. 2007. PhD Thesis, University of London.
43. de Koning-Ward T.F., Olivieri A., Bertuccini L., et al. The role of osmiophilic bodies and Pfg377 expression in female gametocyte emergence and mosquito infectivity in the human malaria parasite Plasmodium falciparum. Mol Microbiol 67 (2008) 278-290